ArticleThe Journal of clinical endocrinology and metabolism2025
Familial Risk of Hashimoto's Thyroiditis in a Large Genealogical Database.
Article in The Journal of clinical endocrinology and metabolism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Familial Risk of Hashimoto's Thyroiditis in a Large Genealogical Database.The Journal of clinical endocrinology and metabolism · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
contextAutoimmune hypothyroidism, commonly known as Hashimoto thyroiditis (HT), is an autoimmune thyroid disorder affecting approximately 5% of the US population. Previous relative risk studies have suggested that first-degree relatives of individuals with HT are at ∼4.5 to 32 times higher risk for developing HT than the general population. Twin studies estimate high heritability for the development of HT (∼65%).
objectiveIn this study, we aimed to better estimate the HT relative risk in first-, second-, and third-degree relatives in the Utah Population Database.
methodsFrom the Utah Population Database, a total of 92 405 HT probands and 184 810 matched controls were identified, with 2 960 650 relatives of HT probands and 5 730 159 relatives of controls, making this the largest relative risk study of HT.
resultsFemales with HT in this cohort were 2.71-fold more common than males. The odds ratio (OR) of HT in the first-degree relatives of affected individuals is 1.77 (95% CI, 1.74-1.80). The OR of HT in second-degree relatives is 1.23 (95% CI, 1.22-1.27) and 1.11 (95% CI, 1.10-1.12) in third-degree relatives of HT probands. We also identified an increased OR of spouses to develop HT of 1.50 for husbands of affected wives (95% CI, 1.39-1.61) and 1.58 for wives of affected husbands (95% CI, 1.47-1.70), suggesting a significant environmental component contributing to HT development.
conclusionThis is the first study to estimate an increased risk of HT for second- and third-degree relatives, who are less likely to share common environments than first-degree relatives.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.